BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18193094)

  • 21. Estrogen-dependent responses of the mammary fat pad in prepubertal dairy heifers.
    Meyer MJ; Capuco AV; Boisclair YR; Van Amburgh ME
    J Endocrinol; 2006 Sep; 190(3):819-27. PubMed ID: 17003282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
    Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-growth factor activities of benzothiophenes in human breast cancer cells.
    Freiss G; Galtier F; Puech C; Aknin C; Maudelonde T; Chalbos D; Vignon F
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):451-60. PubMed ID: 15876410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
    Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
    Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.
    Dahm AE; Iversen N; Birkenes B; Ree AH; Sandset PM
    BMC Cardiovasc Disord; 2006 Oct; 6():40. PubMed ID: 17029634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective estrogen receptor modulators inhibit the effects of insulin-like growth factors in hyperparathyroidism.
    Wong C; Lai T; Hilly JM; Stewart CE; Farndon JR
    Surgery; 2002 Dec; 132(6):998-1006; discussion 1006-7. PubMed ID: 12490847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of estrogen receptor-alpha and targets of estrogen receptor action in proliferating monkey mammary epithelial cells.
    Dimitrakakis C; Zhou J; Wang J; Matyakhina L; Mezey E; Wood JX; Wang D; Bondy C
    Breast Cancer Res; 2006; 8(1):R10. PubMed ID: 16417658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells.
    Kawagoe J; Ohmichi M; Tsutsumi S; Ohta T; Takahashi K; Kurachi H
    Endocrinology; 2007 Dec; 148(12):6092-9. PubMed ID: 17872375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of SERMs on bone health. SERM actions other than on the bones. With special reference to the actions of SERM on the skin and vascular elasticity].
    Sumino H; Ichikawa S
    Clin Calcium; 2010 Mar; 20(3):388-94. PubMed ID: 20190369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro.
    Liu J; Matsuo H; Xu Q; Chen W; Wang J; Maruo T
    Hum Reprod; 2007 May; 22(5):1253-9. PubMed ID: 17220163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen and raloxifene inhibit the monocytic chemoattractant protein-1-induced migration of human monocytic cells via nongenomic estrogen receptor alpha.
    Yada-Hashimoto N; Nishio Y; Ohmichi M; Hayakawa J; Mabuchi S; Hisamoto K; Nakatsuji Y; Sasaki H; Seino-Noda H; Sakata M; Tasaka K; Murata Y
    Menopause; 2006; 13(6):935-41. PubMed ID: 17006379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs.
    Somjen D; Shen M; Stern N; Mirsky N
    J Cell Biochem; 2006 Sep; 99(1):133-9. PubMed ID: 16598752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
    Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
    Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
    Koda M; Jarzabek K; Haczynski J; Knapp P; Sulkowski S; Wolczynski S
    Oncol Rep; 2004 Sep; 12(3):517-21. PubMed ID: 15289830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta.
    Rotinen M; Celay J; Alonso MM; Arrazola A; Encio I; Villar J
    J Endocrinol; 2009 Jan; 200(1):85-92. PubMed ID: 18852215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.